Abstract
growth and survival of tumor cells, since a number of plant substances and closely related chemical entities are potent luciferase inhibitors: Resveratrol (3,5,4′-trihydroxy-transstilbene) is a powerful inhibitor of firefly luciferase with an IC50 of approximately 1–2 μM (Bakhtiarova et al. 2006; Braeuning and Vetter 2012), as is the structurally related NFκB inhibitor (E)-2-fluoro-4′-methoxystilbene (Braeuning and Vetter 2012). Certain flavonoids, for example, the kinase inhibitor PD98,059 (2′-amino-3′-methoxyflavone) and the widely used aryl hydrocarbon receptor agonist β-naphthoflavone, also inhibit firefly luciferase at concentrations far below what is routinely used for in vitro assays (Auld et al. 2008; Vaas et al. 2014; Wang 2002). It is quite difficult to find a paper in the literature where the possibility of luciferase enzyme inhibition has been explicitly taken into account by the authors. This does, however, not necessarily mean that all luciferase reporter assays conducted with cells treated with substances such as resveratrol must have yielded inconclusive results (nor do problems with a luciferase reporter assay invalidate the findings obtained with other experimental approaches which are presented in the same paper). A long time of incubation with resveratrol rather seems to reduce the problem of luciferase-inhibitory effects by resveratrol (Braeuning and Vetter 2012), most likely by conversion of resveratrol to less-active metabolites. This time dependency has only been demonstrated for a few cell lines (Braeuning and Vetter 2012) and will most probably differ substantially between individual lines. However, resveratrol is routinely used in concentrations of up to 100 μM which does by far exceed the concentrations used for luciferase inhibition in the aforementioned study. It thus often remains uncertain whether a reduction in firefly luciferase reporter activity observed under resveratrol treatment is in fact caused by the reduced transactivation potential of the transcription Numerous research groups are engaged in the analysis of the interference of plant constituents with the growth and survival of cancer cells. Among others, the polyphenolic trans-stilbene resveratrol and various flavonoids are extensively studied in this context. These compounds are generally thought to act in a cytoprotective, anti-tumorigenic manner, probably via their antioxidant and anti-inflammatory properties or by their ability to enhance the cytotoxicity of anticancer drugs. The underlying molecular details are addressed by an increasing number of publications, often by tracing back alterations in biological endpoints, e.g., apoptosis, to a substance-dependent disturbance of distinct cellular signaling pathways and transcription factors. For a recent review of resveratrol effects on the activity of various transcription factors, see Whitlock and Baek (2012). Luciferase-based reporter assays are among the most frequently used experimental tools to analyze the activity of downstream transcription factors of interest. Unfortunately, an important confounder of luciferase reporter assays is still neglected by most researchers in the field. As many other enzymes, Photinus pyralis-derived firefly luciferase is subject to inhibition by chemicals acting as competitive or non-competitive inhibitors of the protein’s catalytic activity, as reviewed by Auld et al. (2008) and by Leitao and Esteves da Silva (2010). In a routine assay setup, direct inhibition of the reporter enzyme by a substance present in the cell lysate cannot be easily distinguished from an inhibition of reporter gene transcription, if proper controls are missing. This is of pivotal importance for the research related to nutritional effects on the
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.